During the past decade, Peter MacCallum Cancer Centre; Department of Haematology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Peter MacCallum Cancer Centre; Department of Haematology" #1 collaborator was "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Peter MacCallum Cancer Centre; Department of Haematology" are "Chronic Lymphocytic Leukemia (CLL)" (1 trials), "Lymphocytic Leukemia, Chronic, Diffuse Large B-Cell Lymphoma" (1 trials), "Lymphoma, Non-Hodgkin" (1 trials), "Multiple Myeloma" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Peter MacCallum Cancer Centre; Department of Haematology" in a lesser frequency.

Most popular intervention types in "Peter MacCallum Cancer Centre; Department of Haematology" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Obinutuzumab" (3 trials), "Bendamustine" (2 trials), "Cyclophosphamide" (2 trials), "Rituximab" (2 trials) and "Tocilizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Peter MacCallum Cancer Centre; Department of Haematology" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Peter MacCallum Cancer Centre; Department of Haematology". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Peter MacCallum Cancer Centre; Department of Haematology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Peter MacCallum Cancer Centre; Department of Haematology, 3 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".